Literature DB >> 25893493

[Psychosocial Treatment of Addictive Disorders--An Overview of Psychotherapeutic Options and their Efficacy].

M Walter, K M Dürsteler, S A Petitjean, G A Wiesbeck, S Euler, D Sollberger, U E Lang, M Vogel.   

Abstract

Addictive disorders are chronic relapsing conditions marked by compulsive and often uncontrolled use of psychotropic substances or stimuli. In this review, we present and discuss the current specific psychosocial interventions for addictive disorders and their effectiveness. In particular cognitive behavioral therapy, motivational interviewing, relapse prevention, the community reinforcement approach, and contingency management were found to be effective. For these psychotherapeutic treatments, mostly moderate effect sizes have been found. Their effectiveness seems to be highest in cannabis dependence. Empirical evidence for dependence on "hard" drugs is largest for contingency management, while for alcohol dependence motivational interviewing and the community reinforcement approach show the largest effect sizes. Presumably, combinations of different approaches as well as online interventions will bring further progress in the psychosocial treatment of addictive disorders in the future. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2015        PMID: 25893493     DOI: 10.1055/s-0034-1399338

Source DB:  PubMed          Journal:  Fortschr Neurol Psychiatr        ISSN: 0720-4299            Impact factor:   0.752


  2 in total

Review 1.  Alcohol Dependence and Harmful Use of Alcohol.

Authors:  Anil Batra; Christian A Müller; Karl Mann; Andreas Heinz
Journal:  Dtsch Arztebl Int       Date:  2016-04-29       Impact factor: 5.594

2.  Functional and clinical outcomes of FMRI-based neurofeedback training in patients with alcohol dependence: a pilot study.

Authors:  Susanne Karch; Daniela Krause; Marco Paolini; Daniel Keeser; Kevin Lehnert; Julia Konrad; Dinah Haller; Boris-Stephan Rauchmann; Maximilian Maywald; Hessel Engelbregt; Kristina Adorjan; Gabriele Koller; Paul Reidler; Temmuz Karali; Nadja Tschentscher; Birgit Ertl-Wagner; Oliver Pogarell
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-10-07       Impact factor: 5.760

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.